Bhutan lines up cancer vaccine

June 16, 2010

BRISBANE: A Brisbane cancer charity will vaccinate an entire generation of women in a poor Asian country in a bid to save thousands of lives.

Australian Cervical Cancer Foundation has formed an partnership with Merck, Sharp & Dohme Corporation the manufacturer of cervical cancer vaccine Gardasil and the Government of Bhutan to vaccinate the entire eligible female population of the developing nation.

The retail value of the inoculations is about $40 million.

In total, 103,000 Bhutanese females, aged between 12 and 18, will be vaccinated over a six-year period.

Former criminal defence lawyer and ACCF chief executive Joe Tooma launched the program in Bhutan last month.

“Bhutanese women are the centre of their families and when cervical cancer vaccination saves women’s lives, it also safeguards their families and communities,” he said.

“The resulting improved health outcomes for women will contribute to this unique Himalayan nation’s policy of Gross National Happiness, by reducing deaths and suffering caused by cervical cancer.”




Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.